$IXHL (#nasdaq) video presentation on #Incannex proprietary IHL-42X drug candidate prospective for obstructive sleep apnea. Phase 2/3 studies have commenced following positve Phase 2 proof of concept trial. #investing#trading#sleepapnea
Watch on #Vimeo https://t.co/jX5Gk2Nr5I
$IHL (#ASX) $IXHL (#nasdaq) #ASXnews announcement: #Incannex expands intellectual property position over IHL-42X, filing a provisional patent over IHL-42X mechanism of action in treatment of Obstructive #SleepApnea (‘OSA’).
#FDA#cbd#thc
Read here: https://t.co/PxqnWJWs0G
$IHL $IXHL It is no surprise to me that demand is coming for @ASX_IHL . Beautiful to watch. Regardless of where it closes today. We are going to continue to see all time highs in the future.